Search research articles
Contact Us
Filters
Showing results (331-340 of 357) with videos related to
Page
of 36
Sort By:
Molecular Neurobiology
|
May 27, 2023
The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis
Jennilee M Davidson, Sharlynn S L Wu, Stephanie L Rayner, et al.
Journal of Neuroinflammation
|
May 2, 2026
ALS-FTD-linked CCNF<sup>S621G</sup> drives increased hippocampal astrocyte ramification and mitochondrial dysfunction and impairs motor neuron excitability
Liam Robinson, Dzung Do-Ha, Flora Cheng, et al.
The European Journal of Neuroscience
|
August 14, 2021
Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis
Amanda L Wright, Paul A Della Gatta, Sheng Le, et al.
Human Molecular Genetics
|
October 30, 2018
Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype
Alison L Hogan, Emily K Don, Stephanie L Rayner, et al.
Scientific Reports
|
November 22, 2023
ALS/FTD-associated mutation in cyclin F inhibits ER-Golgi trafficking, inducing ER stress, ERAD and Golgi fragmentation
Audrey M G Ragagnin, Vinod Sundaramoorthy, Fabiha Farzana, et al.
Human Molecular Genetics
|
April 27, 2017
Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype
Alison L Hogan, Emily K Don, Stephanie L Rayner, et al.
Open Biology
|
October 13, 2017
Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF<sup>(cyclin F)</sup> complex
Albert Lee, Stephanie L Rayner, Alana De Luca, et al.
Cancers
|
June 27, 2024
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials
Neil J Shah, Alexandra Della Pia, Tianmin Wu, et al.
Cancer Cell
|
February 12, 2015
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer
Samuel J Vidal, Veronica Rodriguez-Bravo, S Aidan Quinn, et al.
Molecular Cancer
|
February 21, 2024
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma
Valentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 357) with videos related to
Sort By:
Page
of 36
Molecular Neurobiology
|
May 27, 2023
The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis
Jennilee M Davidson, Sharlynn S L Wu, Stephanie L Rayner, et al.
Journal of Neuroinflammation
|
May 2, 2026
ALS-FTD-linked CCNF<sup>S621G</sup> drives increased hippocampal astrocyte ramification and mitochondrial dysfunction and impairs motor neuron excitability
Liam Robinson, Dzung Do-Ha, Flora Cheng, et al.
The European Journal of Neuroscience
|
August 14, 2021
Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis
Amanda L Wright, Paul A Della Gatta, Sheng Le, et al.
Human Molecular Genetics
|
October 30, 2018
Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype
Alison L Hogan, Emily K Don, Stephanie L Rayner, et al.
Scientific Reports
|
November 22, 2023
ALS/FTD-associated mutation in cyclin F inhibits ER-Golgi trafficking, inducing ER stress, ERAD and Golgi fragmentation
Audrey M G Ragagnin, Vinod Sundaramoorthy, Fabiha Farzana, et al.
Human Molecular Genetics
|
April 27, 2017
Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype
Alison L Hogan, Emily K Don, Stephanie L Rayner, et al.
Open Biology
|
October 13, 2017
Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF<sup>(cyclin F)</sup> complex
Albert Lee, Stephanie L Rayner, Alana De Luca, et al.
Cancers
|
June 27, 2024
Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials
Neil J Shah, Alexandra Della Pia, Tianmin Wu, et al.
Cancer Cell
|
February 12, 2015
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer
Samuel J Vidal, Veronica Rodriguez-Bravo, S Aidan Quinn, et al.
Molecular Cancer
|
February 21, 2024
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma
Valentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Page
of 36